Treatment of overt CNS leukemia
作者:
G. Humphrey,
Henry Krous,
Janice Filler,
James Maxwell,
Jean VanHoutte,
期刊:
American Journal of Pediatric Hematology/Oncology
(OVID Available online 1979)
卷期:
Volume 1,
issue 1
页码: 37-48
ISSN:0192-8562
年代: 1979
出版商: OVID
数据来源: OVID
摘要:
At this time, methotrexate and CNS radiotherapy used together offer the best chance for prolonged remissions in children who develop overt CNS leukemia. Toxicity is a major problem. Unless a lower dose of radiation is used, the contribution of radiotherapy to neurotoxicity cannot be reduced. However, the toxicity of intrathecal methotrexate can be reduced by using Elliot's B as a diluent, combining methotrexate with hydrocortisone, and using a standard dose after the age of 3 years rather than a dose based on body surface area.Fortunately, the incidence of CNS leukemia has decreased over the years due to prophylactic CNS therapy. However, when a CNS relapse does occur, it carries a grave prognosis and is therefore still a significant problem necessitating continued research.
点击下载:
PDF
(737KB)
返 回